Doctor profile · Federal record
Dr. STRUTHA ROUSE, M.D.
Ophthalmology Physician (CMS: OPHTHALMOLOGY) · Ophthalmology Physician · Retina Specialist (Ophthalmology) Physician · Retina Specialist (Ophthalmology) Physician · CHARLOTTE, NC
- NPI 1508819301
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 26 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
135 S SHARON AMITY RD, SUITE #100
CHARLOTTE, NC 282112842
(704) 365-0555
fax (704) 367-8120 - Mailing address
-
PO BOX 60160
CHARLOTTE, NC 282600160
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- January 6, 2020
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State licenses (2)
- North Carolina #2006-01284 · South Carolina #29558
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1508819301. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
29,349
Distinct HCPCS
10
Medicare allowed
$2,385,527
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 22,140 | 56 | $37 | |
92014 |
Established patient complete exam of visual system | 1,943 | 755 | $121 | |
92134 |
Imaging of retina | 1,581 | 773 | $38 | |
67028 |
Injection of drug into eye | 1,150 | 220 | $119 | |
J0178 |
Injection, aflibercept, 1 mg | 1,068 | 114 | $868 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 490 | 21 | $229 | |
92235 |
Exam of retinal blood vessels using a special camera after injection of a dye | 432 | 283 | $129 | |
J9035 |
Injection, bevacizumab, 10 mg | 302 | 75 | $71 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 97 | 87 | $114 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 59 | 59 | $158 |
In context: peer comparison
Among 31 peers in this city , average services per provider: 676. This provider delivers 43× the peer median.Open Payments
Industry payments received
All-time total
$511
Transactions
14
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 4 | $125.12 | |
| Apellis Pharmaceuticals, Inc. | 1 | $119.81 | |
| ABBVIE INC. | 2 | $83.85 | |
| Amgen Inc. | 2 | $58.06 | |
| Harrow Eye, LLC | 1 | $34.49 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $27.41 | |
| Genentech USA, Inc. | 1 | $22.57 | |
| RxSight Inc | 1 | $21.34 | |
| Bausch & Lomb Americas Inc. | 1 | $18.57 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
723
Patients
251
Total drug cost
$78,057
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 212 | 107 | $12,567 |
| Diclofenac Sodium | Generic | 97 | 39 | $1,413 |
| Prolensa (Bromfenac Sodium) | Brand | 85 | 26 | $32,380 |
| Ofloxacin | Generic | 56 | 52 | $748 |
| Brimonidine Tartrate | Generic | 53 | 14 | $3,138 |
| Timolol Maleate | Generic | 42 | 13 | $640 |
| Lotemax Sm (Loteprednol Etabonate) | Brand | 27 | 0 | $8,475 |
| Dorzolamide Hcl | Generic | 25 | 0 | $834 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 23 | 0 | $442 |
| Difluprednate | Generic | 21 | 0 | $2,453 |